AIM held eight listening sessions with immunization program managers (PMs) during the Vaccine Access Cooperative (VAC) Regional Meetings for adult immunization from May-July 2024. The goal of these listening sessions was to understand the successes and challenges jurisdictions and immunization programs (IPs) experienced with COVID-19 vaccination in children ages 11 years and younger post COVID-19 vaccine commercialization. These listening sessions were conducted in the spring and summer 2024 following COVID-19 commercialization. The report summarizes the findings from the eight listening sessions.
COVID-19 Pediatric Vaccination Commercialization Listening Sessions Report
Related Resources
Birthing Institutions and the Vaccines for Children Program
This handout outlines how birthing institution participation in VFC can ensure equitable access to vaccines, save money, and protect newborns from RSV and hepatitis B.
American Academy of Pediatrics (AAP) Chapter Immunization Representatives (CIRs)
The American Academy of Pediatrics (AAP) is updating the roster of Chapter Immunization Representatives (CIRs) and is seeking to maintain an updated listing.
Request for Interest Forms: Community of Practice to Optimize Administration of Birth Dose Immunizations
AIM invites participation in its Immunization Program and Birthing Institution Community of Practice (CoP) to Optimize Administration of Birth Dose Immunizations.